Trial intelligence / Profile preview

Efficacy and Safety of Fibrin Sealant VH S/D in Total Hip Replacement

NCT00161902Phase 3Completed

Sponsor
Baxter
Start
Aug 2001
Modality
Implantable Devices, Transdermal Patches, Recombinant Proteins and Enzymes
Countries
3
01

Overview

A Phase 3 trial of tisseel, sponsored by Baxter. Started Aug 2001; status: completed.

02

Drugs

tisseel

Beyond the preview

Go deeper on NCT00161902.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00161902.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call